Skip to main content
Figure 1 | Journal of Ovarian Research

Figure 1

From: Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)

Figure 1

Representative microphotographs of FSHR (A, B) and Her-2 (C, D) immunostaining are shown. Patients were stratified according to their FSHR expression status (FSHR negative (A), FSHR positive (B)). The prognostic significance of Her-2 positivity (D) as compared to Her-2 non expressing (C) cases has been evaluated. Scale bars in (A) equal 100 μm and refer to A-D.

Back to article page